Genomic Sequencing

Smith and colleagues developed the GENEtic Utility (GENE-U) scale to assess the perceived utility of genetic screening from the perspective of those who are undergoing risk-based or population-based screening via genetic screening.

Lainie Friedman Ross

Read more about Lainie Friedman Ross

Health Care for Newborns and Minors|\Genetic Screening

Organ transplantation

Research Ethics

Treatment Refusal

Genomic Sequencing

When "actionable" genomic sequencing results cannot be acted upon

Read more about When "actionable" genomic sequencing results cannot be acted upon

Respecting autonomy and balancing benefits by disclosing the secondary finding of Klinefelter’s

Read more about Respecting autonomy and balancing benefits by disclosing the secondary finding of Klinefelter’s

Clarifying the blurry boundaries between research and clinical care

Read more about Clarifying the blurry boundaries between research and clinical care

The importance of defining actionability as related to disclosure of secondary findings identified in research

Read more about The importance of defining actionability as related to disclosure of secondary findings identified in research

When to disclose a borderline incidental finding

Read more about When to disclose a borderline incidental finding

To disclose or not to disclose: Secondary findings of XXY chromosomes

Read more about To disclose or not to disclose: Secondary findings of XXY chromosomes

Interview Guide: Genetic Health Professionals’ Experiences with Informed Consent in Diagnostic Genomic Sequencing

Read more about Interview Guide: Genetic Health Professionals’ Experiences with Informed Consent in Diagnostic Genomic Sequencing

This interview guide seeks to understand genetic health professionals' experiences with obtaining informed consent for diagnostic genomic sequencing from patients.

Select ethical aspects of next-generation sequencing tests for newborn screening and diagnostic evaluation of critically ill newborns

Read more about Select ethical aspects of next-generation sequencing tests for newborn screening and diagnostic evaluation of critically ill newborns

Newsletter